港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

抗疫概念

882.663

+33.2363.91%

涨家数：18

跌家数：- -

平家数：- -

市盈率：- -

高：886.237

开：850.659

低：850.659

收：849.427

数据加载中...

A股午后医药板块持续走高，创新药方向继续领涨，众生药业、华森制药、富士莱涨停，百利天恒、诺诚健华、新诺威、百济神州创历史

复星医药，增持复宏汉霖至63.43%

济南比亚迪半导体申请图像生成专利，保障目标图像与用户视觉习惯匹配

去年北京追回医保基金4.64亿元

刘强东火锅谈话全文：“老兄弟”退休金不低于5000

港股医药逆势走强港股医药ETF涨超3% 冲击四连涨

东方财富证券

港股概念追踪|生物医药去库存周期尾声原料药+创新药受益国产替代（附概念股）

3月插混战报：吉利/奇瑞猛追比亚迪，长安/问界挑战理想

Ofweek光电信息网

复宏汉霖盘中涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权

港股异动 | 复宏汉霖(02696)再涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权

【白云山(00874.HK)：明兴药业收到广东省药品监督管理局核准签发的《药品生产许可证》】白云山(00874.HK)发布公告，近日，该公司子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》，同意明兴药业核减生产范围、生产车间和生产线。

诺和诺德与京东健康开启战略合作，将共同打造肥胖症科普专区

白云山(00874)：明兴药业收到广东省药品监督管理局核准签发的《药品生产许可证》

智通财经网

【港股医药股走强歌礼制药涨近18%】截至发稿，歌礼制药-B(01672.HK)涨17.81%、荣昌生物(09995.HK)涨10.06%、映恩生物-B(09606.HK)涨9%、来凯生物-B(02105.HK)涨8.25%。

总规模10亿元中生引领基金揭牌，浦东创投、中国生物制药等为首关出资人

港股创新药板块走强，歌礼制药(01672.HK)涨超20%，荣昌生物(09995.HK)、石药集团(01093.HK)涨

港股异动 | 歌礼制药-B(01672)早盘涨超22% 礼来公布口服降糖药积极结果 ASC30具备更大商业化BD潜力

年内基金业绩排名生变：北交所、医药崛起，机器人板块退潮

石药集团盘中异动早盘股价大涨5.04%

东阳光长江药业盘中异动股价大涨5.04%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1515/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":882.6631,"timestamp":1745309290509,"preClose":849.42694,"halted":0,"volume":571779316,"delay":0,"changeRate":0.039128,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":33.236145,"latestTime":"04-22 16:00:00","open":850.65875,"high":886.2366,"low":850.65875,"amount":3791149528.5,"amplitude":0.041884,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745371800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745285400000,1745294400000],[1745298000000,1745308800000]],"pbRate":1.548396,"peRate":20.662208,"turnoverRate":0.007583,"increases":18,"decrements":0,"flats":0,"marketCap":610485035392,"floatMarketCap":500669397888},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":886.2366,"amplitude":0.041884,"preClose":849.42694,"low":850.65875,"pbRate":"1.548396","latestPrice":882.6631,"volume":571779316,"delay":0,"open":850.65875,"prevYearClose":787.97723,"prevWeekClose":849.427,"prevMonthClose":870.015,"prevQuarterClose":870.015,"fiveDayClose":840.443,"twentyDayClose":934.049,"sixtyDayClose":758.629,"secType":"PLATE","market":"HK","turnoverRate":0.007583,"peRate":20.662208,"marketCap":610485035392,"floatMarketCap":500669397888,"timestamp":1745309290509,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":18,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529701316","title":"A股午后医药板块持续走高，创新药方向继续领涨，众生药业、华森制药、富士莱涨停，百利天恒、诺诚健华、新诺威、百济神州创历史","url":"https://stock-news.laohu8.com/highlight/detail?id=2529701316","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529701316?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 13:47","pubTimestamp":1745300842,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002294","688506","688235","01349","BK0077","159992","688505","BK1583","ONC","159982","06160","LU1969619763.USD","BK1161","BK0196","301258","BK1500","09969","399300","BK0239","002317","688428","BK0187","688091","300765","BK1574","BK0226","BK1191","BK0028","LU0307460666.USD","159938","LU2328871848.SGD","BK4139","688068","BK1588","LU0588546209.SGD","002907","BK0183","BK1515","BK0188","09939","06978"],"gpt_icon":0},{"id":"2529124313","title":"复星医药，增持复宏汉霖至63.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529124313","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529124313?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 13:03","pubTimestamp":1745298180,"startTime":"0","endTime":"0","summary":"　　复星医药发公告指，上周四斥资3.68亿港元增持复宏汉霖约1494.07万股非上市股份，平均每股作价24.6港元，卖方为生物科技投资公司HenLink。　　复星医药又在4月15日与舟山果运签订股份转让协议，向对方收购138.12万股复宏汉霖非上市股份，每股代价为24.6港元，涉3397.75万港元。　　上述数项交易完成后，复星医药持有复宏汉霖股权比例会由59.56%增加至63.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-22/doc-inetzkuw4200955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK1593","BK0028","600196","02196","BK0175","02696","BK0183","BK0060","BK0096","BK0188","BK0196","BK0187","BK0239","BK1161","BK1515","BK0012"],"gpt_icon":0},{"id":"2529390545","title":"济南比亚迪半导体申请图像生成专利，保障目标图像与用户视觉习惯匹配","url":"https://stock-news.laohu8.com/highlight/detail?id=2529390545","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529390545?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 12:01","pubTimestamp":1745294502,"startTime":"0","endTime":"0","summary":"金融界2025年4月22日消息，国家知识产权局信息显示，济南比亚迪半导体技术有限公司申请一项名为“图像生成方法、控制装置、电子装置、车辆及存储介质”的专利，公开号CN119854643A，申请日期为2024年8月。通过天眼查大数据分析，济南比亚迪半导体技术有限公司共对外投资了2家企业，参与招投标项目2次，专利信息45条，此外企业还拥有行政许可1个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042212130994dd9e4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042212130994dd9e4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828714.EUR","LU1720050803.USD","LU0979878070.USD","SG9999015945.SGD","LU1023057109.AUD","BK1610","LU0516422440.USD","LU2249611893.SGD","LU0289961442.SGD","LU1861219969.SGD","00285","BK1515","81211","LU0269904917.USD","BK1119","LU0348735423.USD","LU1719994722.HKD","LU1861214812.USD","LU2399975544.HKD","SG9999015986.USD","BK1149","LU0214875030.USD","LU0449515922.USD","002594","HYDD.SI","LU0229945570.USD","LU1880383366.USD","LU0516422952.EUR","LU0865486749.SGD","LU0143863198.USD","LU0143863784.USD","LU0315178854.USD","LU0463099449.HKD","LU0511384066.AUD","LU0593848301.USD","LU0054450605.USD","BYDDY","LU0274383008.USD","LU0348805143.USD","LU2476274308.USD","LU2360107325.USD","LU0561508036.HKD","LU0327786744.USD","LU0516422366.SGD","01211","LU2097828805.USD","BK1504","LU2097828474.EUR","LU1794554557.SGD","LU0348825331.USD"],"gpt_icon":1},{"id":"2529392335","title":"去年北京追回医保基金4.64亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529392335","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529392335?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 11:47","pubTimestamp":1745293635,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","BK1161","159938","BK1515","09939"],"gpt_icon":0},{"id":"2529391065","title":"刘强东火锅谈话全文：“老兄弟”退休金不低于5000","url":"https://stock-news.laohu8.com/highlight/detail?id=2529391065","media":"蓝鲸新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529391065?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 11:15","pubTimestamp":1745291726,"startTime":"0","endTime":"0","summary":"4月21日，京东创始人刘强东在亲自参与外卖配送之后，请外卖骑手们吃海底捞火锅。吃饭期间刘强东发表讲话，谈及送外卖的感受、为骑手缴纳五险一金等内容。刘强东称：“京东这种工作稳定，五险一金全齐了。我们老兄弟干了18年，他还可以照样干五年，还没到退休年龄。20多年之后，他离开京东的时候，光公积金一项就要给二三十万现金一次性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384150057.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE0008368742.USD","BK4503","LU0140636845.USD","LU0417516902.SGD","LU1044874839.SGD","BK1247","BK1515","BK4614","LU0345776255.USD","LU0163747925.USD","LU1770034418.SGD","LU0531971595.HKD","LU0588545904.SGD","LU0543330483.HKD","09618","LU0259732245.USD","LU0228367735.SGD","LU0791591158.USD","BK1610","06618","BK4579","LU0865486749.SGD","BK4505","LU0128522157.USD","BK4509","BK1583","LU0359202008.SGD","LU0431992006.USD","LU0307460666.USD","LU1808992512.USD","LU0828237510.HKD","LU0315179316.USD","LU0051755006.USD","LU0588546209.SGD","LU0499858602.USD","LU1282649810.SGD","LU0384037296.USD","LU0417516738.SGD","LU2242644610.SGD","LU1794554557.SGD","SG9999001226.SGD","LU0326950275.SGD","89618","BK1591","LU0048580855.USD","LU1813983027.USD","LU0029875118.USD","LU1688375341.USD","JD","86618"],"gpt_icon":1},{"id":"2529391901","title":"港股医药逆势走强 港股医药ETF涨超3% 冲击四连涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2529391901","media":"东方财富证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529391901?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 11:10","pubTimestamp":1745291400,"startTime":"0","endTime":"0","summary":"4月22日，港股市场集体震荡环境下，港股医药带头领涨，港股医药ETF上涨3.10%，冲击4连涨。成分股石药集团、百济神州、信达生物、再鼎医药、康方生物上涨超 5%。港股医药ETF紧密跟踪中证港股通医药卫生综合指数，中证港股通医药卫生综合指数从港股通范围内选取50只流动性较好、市值较大的医疗卫生行业上市公司证券作为指数样本，以反映港股通范围内医药卫生上市公司证券的整体表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422111145a6c32f7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422111145a6c32f7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004220.SGD","LU1226287529.USD","LU1152091168.USD","LU0880133367.SGD","LU1960683339.HKD","LU0501845795.SGD","LU0140636845.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","HSTECH","LU1226287875.USD","06160","LU0067412154.USD","LU0072913022.USD","LU1226288253.USD","09688","IE0008369823.USD","LU1993786604.SGD","LU1226288170.HKD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","01093","LU1008478684.HKD","IE00B5MMRT66.SGD","LU0326950275.SGD","09926","LU1951186391.HKD","IE0008368742.USD","01801","IE00B543WZ88.USD","LU1226287792.SGD","BK1521","BK1191","LU1807302812.USD","BK1515","IE00B031HY20.USD"],"gpt_icon":1},{"id":"2529204399","title":"港股概念追踪|生物医药去库存周期尾声        原料药+创新药受益国产替代（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2529204399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529204399?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:50","pubTimestamp":1745290214,"startTime":"0","endTime":"0","summary":"探索建立生物医药企业进口研发用物品“白名单”制度，允许免予办理进口药品通关单。中国由于工程师红利、环保及成本优势过往承接全球原料药生产重心转移，为全球主工厂之一。期内总收入为21亿元人民币，其中产品销售收入20亿元人民币，同比增长25%。机构预期康方生物今年的产品销售将同比增长60%至33亿元人民币，受惠今年初AK104和AK112被纳入中国国家医保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226287792.SGD","LU1993786604.SGD","LU0072913022.USD","399441","09995","IE0008369823.USD","06978","IE00BZ08YT58.USD","LU0501845795.SGD","HSTECH","IE0008368742.USD","IE00B031HY20.USD","LU1152091754.HKD","LU1226288253.USD","IE00B5MMRT66.SGD","LU1807302812.USD","BK1515","LU0326950275.SGD","LU0067412154.USD","01093","IE00B543WZ88.USD","IE00BZ08YR35.GBP","SG9999004220.SGD","BK1161","LU1951186391.HKD","LU1969619763.USD","LU1226287875.USD","BK1521","LU1226287529.USD","LU2328871848.SGD","BK1574","BK1191","LU0140636845.USD","LU0880133367.SGD","IE00BZ08YS42.EUR","LU1152091168.USD","BK4614","159992","LU1008478684.HKD","LU1960683339.HKD","YANG","BK1583","161726","LU1226288170.HKD"],"gpt_icon":1},{"id":"2529585791","title":"3月插混战报：吉利/奇瑞猛追比亚迪，长安/问界挑战理想","url":"https://stock-news.laohu8.com/highlight/detail?id=2529585791","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529585791?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:45","pubTimestamp":1745289900,"startTime":"0","endTime":"0","summary":"吉利银河星舰7、银河L6分别以11890辆、8027辆的销量，成为仅次于比亚迪的插混车型。理想：遭遇长安、问界增程车挑战作为增程车市场领导者，理想汽车凭借L6、L7夺得中国增程车型销量冠、亚军，但也遭遇长安、赛力斯、奇瑞等集团的挑战。理想L6销量17,197辆，而理想L7销量已降至8707辆，同比下降19.1%。目前尚无插混/增程车型上市的企业如小鹏汽车、广汽埃安等，也计划推出插混/增程车型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042210561494dd8a7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042210561494dd8a7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0588545490.SGD","LU0175139822.USD","BK1522","LU0634319403.HKD","LU0708995583.HKD","LU0449509016.USD","BK1539","01211","81211","BYDDY","LU1023057109.AUD","LU0516423091.SGD","LU0819123356.HKD","LU0543330566.HKD","LU0417516738.SGD","BK1515","LU0828238088.HKD","LU1861219969.SGD","LU1868837722.USD","LU0327786744.USD","SG9999002463.SGD","LU1770034418.SGD","002594","GELYY","HYDD.SI","BK1504","LU0269904917.USD","LU0315179316.USD","LU2097828714.EUR","LU1251922891.USD","LU0293314216.USD","LU0143863784.USD","LU2360107325.USD","LU0307460666.USD","LU0229945570.USD","SG9999015952.SGD","EVS.SI","LU0274383008.USD","LU0979878070.USD","SG9999001226.SGD","80175","LU0289960550.SGD","LU0516422366.SGD","SG9999014674.SGD","BK1119","LU1242518857.USD","LU1880383440.USD","00175","LU0214875030.USD"],"gpt_icon":1},{"id":"2529395970","title":"复宏汉霖盘中涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2529395970","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529395970?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:42","pubTimestamp":1745289720,"startTime":"0","endTime":"0","summary":"　　复宏汉霖盘中涨超9%，截至发稿，股价上涨8.40%，现报36.80港元，成交额3593.75万港元。　　消息面上，复星医药公布，今年4月11日至17日期间，控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别签订转让协议，控股子公司复星医药产业拟以24.60港元/股的价格受让上海善梧、无锡通善、舟山果运及Henlink合计持有的2103万股复宏汉霖非上市股份，转让价款共计5.17亿港元。在此次增持之后，复星医药持有复宏汉霖的股权比例将增至63.43%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzepa1054800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK0012","02696","BK1593","600196","BK0096","BK0060","BK0028","BK0188","BK1515","02196","BK0175","BK0183","BK0196","BK0239","BK0187","BK1191"],"gpt_icon":0},{"id":"2529393265","title":"港股异动 | 复宏汉霖(02696)再涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2529393265","media":"智通财经","labels":["shareholding","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529393265?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:32","pubTimestamp":1745289125,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖再涨超9%，截至发稿，涨8.54%，报36.85港元，成交额3528.23万港元。消息面上，复星医药公布，今年4月11日至17日期间，控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别签订转让协议，控股子公司复星医药产业拟以24.60港元/股的价格受让上海善梧、无锡通善、舟山果运及Henlink合计持有的2103万股复宏汉霖非上市股份，转让价款共计5.17亿港元。在此次增持之后，复星医药持有复宏汉霖的股权比例将增至63.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","BK0175","BK1593","BK0187","BK1161","600196","BK0060","BK0096","BK0012","02196","BK0183","BK0188","BK0196","BK0239","BK0028","02696"],"gpt_icon":0},{"id":"2529600513","title":"【白云山(00874.HK)：明兴药业收到广东省药品监督管理局核准签发的《药品生产许可证》】白云山(00874.HK)发布公告，近日，该公司子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》，同意明兴药业核减生产范围、生产车间和生产线。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529600513","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529600513?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:08","pubTimestamp":1745287717,"startTime":"0","endTime":"0","summary":"白云山(00874.HK)发布公告，近日，该公司子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》，同意明兴药业核减生产范围、生产车间和生产线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22100849738128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600332","BK0196","BK1574","BK0239","BK0188","BK1606","BK1197","BK1515","BK1521","BK0097","BK1191","BK0183","BK0070","BK0175","BK0096","BK0028","00874","BK0012","01477"],"gpt_icon":0},{"id":"2529539359","title":"诺和诺德与京东健康开启战略合作，将共同打造肥胖症科普专区","url":"https://stock-news.laohu8.com/highlight/detail?id=2529539359","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529539359?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:05","pubTimestamp":1745287505,"startTime":"0","endTime":"0","summary":"新京报讯（记者王卡拉）4月21日，京东健康与诺和诺德在北京签署战略合作协议，将携手打造肥胖症公众科普专区，助力糖尿病一站式诊疗，全面赋能慢病管理数字化转型升级。为了应对严重慢性疾病的挑战，我国将“糖尿病防治行动”列为《健康中国行动（2019-2030年）》15个专项行动之一，并持续推进《“体重管理年”活动实施方案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504223384063334.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384063334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0154236417.USD","BK1142","BK4007","BK4599","BK1571","BK4588","BK4585","BK1247","NVO","LU1093756168.USD","BK1583","LU0456827905.SGD","IE00BZ1G4Q59.USD","BK1615","BK1591","IE00BKVL7J92.USD","BK1589","06618","LU0051755006.USD","BK4532","BK1515","86618","LU1093756325.SGD"],"gpt_icon":1},{"id":"2529360783","title":"白云山(00874)：明兴药业收到广东省药品监督管理局核准签发的《药品生产许可证》","url":"https://stock-news.laohu8.com/highlight/detail?id=2529360783","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529360783?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:05","pubTimestamp":1745287500,"startTime":"0","endTime":"0","summary":"白云山(00874)发布公告，近日，该公司子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》，同意明兴药业核减生产范围、生产车间和生产线。明兴药业白云厂区已实现规模化运作。本次核减生产范围、生产车间和生产线，有利于进一步整合生产资源、优化产能布局，继续保持稳定的生产能力，满足市场需求。本次获得《药品生产许可证》，对本公司当期业绩无重大影响。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-22/doc-inetyyey7952741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","BK0183","600332","BK0012","BK0096","BK1197","BK1521","BK1515","BK1606","BK0188","BK0097","BK0196","BK0028","BK1191","BK0175","BK0239","00874"],"gpt_icon":0},{"id":"2529367183","title":"【港股医药股走强 歌礼制药涨近18%】截至发稿，歌礼制药-B(01672.HK)涨17.81%、荣昌生物(09995.HK)涨10.06%、映恩生物-B(09606.HK)涨9%、来凯生物-B(02105.HK)涨8.25%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529367183","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529367183?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:55","pubTimestamp":1745286903,"startTime":"0","endTime":"0","summary":"截至发稿，歌礼制药-B(01672.HK)涨17.81%、荣昌生物(09995.HK)涨10.06%、映恩生物-B(09606.HK)涨9%、来凯生物-B(02105.HK)涨8.25%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22095549737746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1969619763.USD","BK1161","688331","BK1515","LU2328871848.SGD","01477","LU2148510915.USD","BK1583","01672","02105","LU1064130708.USD","LU1064131003.USD","BK1574","BK1191","159718","09995","BK0239"],"gpt_icon":0},{"id":"2529678053","title":"总规模10亿元中生引领基金揭牌，浦东创投、中国生物制药等为首关出资人","url":"https://stock-news.laohu8.com/highlight/detail?id=2529678053","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529678053?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:53","pubTimestamp":1745286791,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1521","01177","399441","BK1191","161726","BK1589","BK1515"],"gpt_icon":0},{"id":"2529362752","title":"港股创新药板块走强，歌礼制药(01672.HK)涨超20%，荣昌生物(09995.HK)、石药集团(01093.HK)涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362752","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529362752?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:49","pubTimestamp":1745286560,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","LU0501845795.SGD","159992","688235","BK1588","LU1226287792.SGD","LU0307460666.USD","BK1583","IE0008368742.USD","LU1226288253.USD","IE00BZ08YT58.USD","BK4614","07226","09995","LU1152091754.HKD","01801","01672","HSTECH","LU1951186391.HKD","LU1993786604.SGD","BK4139","LU1152091168.USD","HSCEI","LU1226287529.USD","BK1574","01093","IE00BZ08YS42.EUR","LU1226288170.HKD","ONC","LU0880133367.SGD","IE00B5MMRT66.SGD","LU0140636845.USD","BK1500","LU1807302812.USD","SG9999004220.SGD","06978","06160","YANG","688331","BK1521","IE00B031HY20.USD","LU2488822045.USD","LU1008478684.HKD","LU1969619763.USD","LU2328871848.SGD","IE0008369823.USD","01477","BK1515","IE00B543WZ88.USD","BK1161"],"gpt_icon":0},{"id":"2529362850","title":"港股异动 | 歌礼制药-B(01672)早盘涨超22% 礼来公布口服降糖药积极结果 ASC30具备更大商业化BD潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362850","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529362850?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:41","pubTimestamp":1745286075,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B早盘涨超20%，截至发稿，涨20.65%，报5.96港元，成交额1900.82万港元。消息面上，4月14日，辉瑞因潜在肝损伤终止开发GLP-1小分子受体激动剂Danuglipron。4月17日，礼来宣布口服药Orforglipron的III期ACHIEVE-1研究取得积极顶线结果，在糖化血红蛋白管理、体重控制和安全性方面均与注射剂型相仿，即将申报上市。花卉粗昂证券指出，目前歌礼制药旗下ASC30是唯一一款即可以口服，又可以超长效皮下注射的小分子GLP-1药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4533","LU1551013342.USD","LU0256863902.USD","LU1720051017.SGD","IE0009355771.USD","01672","LU2552382132.HKD","LU1974910355.USD","LU2491050071.SGD","LU0097036916.USD","LU2237443978.SGD","LU0096364046.USD","LU1069344957.HKD","BK1515","LU1989771016.USD","SG9999018857.SGD","SGXZ51526630.SGD","LU0058720904.USD","IE00BK4W5L77.USD","LU2750360641.GBP","LLY","LU2237438978.USD","LU1868837136.USD","LU0466842654.USD","LU2237443895.HKD","LU1868836757.USD","LU0820561818.USD","LU2264538146.SGD","LU1551013425.SGD","LU0820561909.HKD","LU1712237335.SGD","LU2552382215.SGD","BK4599","SGXZ99366536.SGD","LU0198837287.USD","LU1988902786.USD","SG9999014914.USD","LU2491049909.HKD","LU2089984988.USD","LU2265009873.SGD","LU0289739699.SGD","LU0320765059.SGD","LU2361044865.SGD","LU2237443622.USD","LU0385154629.USD","LU1093756325.SGD","LU1232071149.USD","01477","LU0122379950.USD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2529163364","title":"年内基金业绩排名生变：北交所、医药崛起，机器人板块退潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2529163364","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529163364?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:36","pubTimestamp":1745285804,"startTime":"0","endTime":"0","summary":"进入二季度以来，行情遭遇调整，今年以来业绩领涨的基金榜单也发生较大变化，北交所主题基金和医药主题基金表现抢眼。东方财富Choice数据显示，截至4月21日，华夏北交所创新中小企业精选两年定开混合以62.36%的收益率暂居榜首，中信建投北交所精选两年定开混合A紧随其后，收益率达61.48%。此外，汇添富北交所创新精选两年定开混合A收益率超过50%。与北交所和医药主题基金的强势表现形成对比的是，重仓机器人概念股的基金净值出现较大回撤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.huanqiu.com/article/4MNQoOblaLW","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_huanqiu","symbols":["BK1515","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"2529127362","title":"石药集团盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529127362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529127362?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:33","pubTimestamp":1745285591,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时33分，石药集团股票出现异动，股价大幅拉升5.04%。截至发稿，该股报5.840港元/股，成交量1757.01万股，换手率0.15%，振幅5.04%。石药集团股票所在的药品行业中，整体涨幅为0.24%。其相关个股中，三生制药、远大医药、先声药业涨幅较大，振幅较大的相关个股有先声药业、远大医药、石药集团，振幅分别为5.22%、5.22%、4.86%。石药集团公司简介：石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093311973ff7b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093311973ff7b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0880133367.SGD","LU0326950275.SGD","LU1226287792.SGD","SG9999004220.SGD","BK1521","01093","IE0008368742.USD","IE00B031HY20.USD","BK1191","IE00BZ08YR35.GBP","LU1993786604.SGD","LU1226288170.HKD","LU1226287875.USD","IE00B5MMRT66.SGD","LU0501845795.SGD","LU1152091168.USD","LU0072913022.USD","LU1226288253.USD","IE00BZ08YT58.USD","LU1960683339.HKD","BK1515","IE00B543WZ88.USD","LU0140636845.USD","LU1951186391.HKD","LU1152091754.HKD","LU1226287529.USD","LU1008478684.HKD","LU0067412154.USD","IE0008369823.USD","IE00BZ08YS42.EUR","LU1807302812.USD"],"gpt_icon":0},{"id":"2529624843","title":"东阳光长江药业盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529624843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529624843?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:32","pubTimestamp":1745285557,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时32分，东阳光长江药业股票出现波动，股价快速拉升5.04%。截至发稿，该股报12.500港元/股，成交量190.34万股，换手率0.29%，振幅4.71%。东阳光长江药业股票所在的药品行业中，整体涨幅为0.25%。其相关个股中，远大医药、三生制药、信达生物涨幅较大，振幅较大的相关个股有远大医药、先声药业、东阳光长江药业，振幅分别为5.22%、4.83%、4.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093237973ff77f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093237973ff77f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":3,"totalSize":432,"code":"91000000","status":"200"}]}}